New patent for Esperion Theraps drug NEXLETOL
Annual Drug Patent Expirations for NEXLETOL Nexletol is a drug marketed by Esperion Theraps Inc and is included in one NDA. It is available from one supplier. There are three…
Source
Annual Drug Patent Expirations for NEXLETOL Nexletol is a drug marketed by Esperion Theraps Inc and is included in one NDA. It is available from one supplier. There are three…
Source
Annual Drug Patent Expirations for ONGENTYS Ongentys is a drug marketed by Neurocrine and is included in one NDA. It is available from two suppliers. There are nine patents protecting…
Source
Annual Drug Patent Expirations for ARNUITY+ELLIPTA Arnuity Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are six patents…
Source
New patent for Glaxosmithkline drug ARNUITY ELLIPTA Read Post »
Annual Drug Patent Expirations for NEXLIZET Nexlizet is a drug marketed by Esperion Theraps Inc and is included in one NDA. It is available from one supplier. There are five…
Source
Annual Drug Patent Expirations for MAVENCLAD Mavenclad is a drug marketed by Emd Serono Inc and is included in one NDA. It is available from one supplier. There are five…
Source
New patent expiration for Emd Serono drug MAVENCLAD Read Post »
This chart shows the drugs with the most patents in Germany. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
Source
Which pharmaceutical drugs have the most drug patents in Germany? Read Post »
This chart shows the pharmaceutical companies with the most ointment dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most ointment dosed drugs…
Source
Which pharmaceutical companies have the most ointment dosed drugs? Read Post »
Annual Drug Patent Expirations for LODOCO Lodoco is a drug marketed by Agepha Pharma Fz and is included in one NDA. It is available from one supplier. There are eight…
Source
Annual Drug Patent Expirations for TOBI+PODHALER Tobi Podhaler is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. There are…
Source
New patent expiration for Mylan Speciality drug TOBI PODHALER Read Post »
This chart shows the pharmaceutical companies with the most patents in Poland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
Source
Which pharmaceutical companies have the most drug patents in Poland? Read Post »